WILMINGTON, Del.--(BUSINESS WIRE)--AIRSUPRA™ (albuterol/budesonide), formerly known as PT027, has been approved in the US for the as-needed treatment or prevention of bronchoconstriction and to reduce ...
AstraZeneca and Teva resolve dispute over asthma med-- AZ reacted quickly when Teva started shipping a generic version of Pulmicort Respules last week, before official patent expiration. The fight ...
As-needed use of albuterol–budesonide has been shown to result in a significantly lower risk of severe asthma exacerbation than as-needed use of albuterol alone among patients with moderate-to-severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback